University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Patents Held by Members of the Department of
Chemical and Biomolecular Engineering

Chemical and Biomolecular Engineering
Research and Publications

3-2-2004

Alcohol oxidase 1 regulatory nucleotide sequences for
heterologous gene expression in yeast
Mehmet Inan
University of Nebraska - Lincoln

Michael Meagher
University of Nebraska - Lincoln, mmeagher@unl.edu

Andrew K. Benson
University of Nebraska-Lincoln, abenson1@unl.edu

Follow this and additional works at: https://digitalcommons.unl.edu/chemengpatent

Inan, Mehmet; Meagher, Michael; and Benson, Andrew K., "Alcohol oxidase 1 regulatory nucleotide
sequences for heterologous gene expression in yeast" (2004). Patents Held by Members of the
Department of Chemical and Biomolecular Engineering. 93.
https://digitalcommons.unl.edu/chemengpatent/93

This Article is brought to you for free and open access by the Chemical and Biomolecular Engineering Research
and Publications at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in
Patents Held by Members of the Department of Chemical and Biomolecular Engineering by an authorized
administrator of DigitalCommons@University of Nebraska - Lincoln.

US006699691B2

(12) United States Patent

(10) Patent N0.:
(45) Date of Patent:

Inan et al.

(54) ALCOHOL OXIDASE 1 REGULATORY
NUCLEOTIDE SEQUENCES FOR
HETEROLOGOUS GENE EXPRESSION IN

US 6,699,691 B2
Mar. 2, 2004

Altschul et al., “Basic Local Alignment Search Tool.” Jour
nal of Molecular Biology, 1990, pp. 403—410, vol. 215, No.
3.

Michael M. Meagher, Lincoln, NE
(US); Andrew K. Benson, Lincoln, NE

Birren et al., “Sequence Analysis, A Laboratory Manual.”
Genome Analysis, 1997, pp. 543—559, vol. 1, Cold Spring
Harbor Laboratory Press.
Carrillo et al., “The Multiple Sequence Alignment Problem
in Biology.” Siam Journal on Applied Mathematics, 1988,

(Us)

pp. 1073—1082, vol. 48, No. 5.

YEAST

(75) Inventors: Mehmet Inan, Lincoln, NE (US);

Coulson A., “High Performance Searching of Biosequence
(73) Assignee: The Board of Regents of the
University of Nebraska, Lincoln, NE

(Us)
(*)

Notice:

Subject to any disclaimer, the term of this
patent is extended or adjusted under 35

U.S.C. 154(b) by 0 days.

(21) Appl. No.: 10/116,993
(22) Filed:
Apr. 5, 2002
(65)

Prior Publication Data
US 2003/0044947 A1 Mar. 6, 2003

Database.” Trends in Biotechnology, 1994, pp. 76—80, vol.

12, No. 3(122).
Cregg et al., “Functional Characterization of TWo Alcohol
Oxidase Genes from the Yeast Pichia pastoris.” Molecular
and Cellular Biology, 1989, pp. 1316—1323, vol. 9, No. 3.
Cregg et al., “Recombinant Protein Expression in Pichia

pastoris.” Molecular Biotechnology, 2000, pp. 23—52, vol.
16, No. 1.
Cregg et al., “Recent Advances in the Expression of Foreign
Genes in Pichia pastoris.” Biotechnology, 1993, pp.
905—910, vol. 11, No. 8.
Devereux et al., “A Comprehensive set of Sequence Analy
sis Programs for the VAX.” Nucleic Acids Research, 1984,
pp. 387—395, vol. 12, No. 1.

(51)

Int. Cl.7 ......................... .. C12P 21/02; C12N 1/00;

Guarente et al., “Fusion of Escherichia coli lacZ to Cyto
chrome c gene of Saccharomyces cervevisiae.” Proceedings
of the National Academy of Sciences of the USA, 1981, pp.
2199—2203, vol. 78, No. 4.
KoutZ et al., “Structural Comparison of the Pichia pastoris

C12N 1/15; C12N 5/10; C12N 15/11; C12N 15/63

Alcohol Oxidase Genes.” Yeast, 1989, pp. 167—177, vol. 5,

(52)

US. Cl. ................. .. 435/69.1; 435/243; 435/254.2;

Related US. Application Data
(60)

Provisional application No. 60/281,861, ?led on Apr. 5,
2001.

435/2554; 435/255.5; 435/255.6; 435/320.1;
435/325; 435/419; 536/24.1
(58)

Field of Search .................... .. 536/24.1; 435/320.1,

435/325, 419, 243, 69.1
(56)

References Cited
U.S. PATENT DOCUMENTS

EP
EP
EP
W0

Ohi et al., “The Positive and Negative cis—acting Elements
for Methanol Regulation in the Pichia pastorisAOXZ gene.”
Mol. Gen. Genet, 1994, pp. 489—499, vol. 243, No. 5.

Miller J.H. (ed), “Experiment 48, Assay of [3—Galactosi
dase.” Experiments in Molecular Genetic, Cold Spring Har
bor Laboratory, 1972, pp. 352—355.
Sears et al., “A Versatile Set of Vectors for Constitutive and

Regulated Gene Expression in Pichia pastoris.” Yeast, 1998,

5,500,483 A
5,594,115 A
5,641,661 A

3/1996 Kumagai et al.
1/1997 Sharma
6/1997 Kumagai et al.

pp. 783—790, vol. 14, No. 5.
Meinkoth et al., “Hybridization of Nucleic Acids Immobi
liZed on Solid Supports.” Analytical Biochemistry, 1984, pp.
267—284, vol. 138, No. 1.
Tschopp et al., “Expression of lacZ gene from tWo Metha
nol—regulated Promoters in Pichia pastoris.” Nucleic Acids
Research, 1987, pp. 3859—3877, vol. 15, No. 9.

5,935,824 A

8/1999 Sgarlato

* cited by examiner

6,033,898 A

3/2000 Sarthy et al.

4,703,004 A
4,782,137 A
4,855,231 A

10/1987 Hopp et al.
11/1988 Hopp et al.
8/1989 Stroman et al.

5,032,516 A
5,166,329 A

7/1991 Cregg
11/1992 Cregg

FOREIGN PATENT DOCUMENTS
EP

No. 3.

0 226 752 A1
0244598

0 483 115 A2
0 560 401 A1
W0 97/ 12044

7/1987
* 11/1987

4/1992
9/1993
4/1997

OTHER PUBLICATIONS

Ellis, et al., “Isolation of Alcohol Oxidase and TWo Other
Methanol Regulatable Genes from the Yeast Pichia pas

toris”, Molecular and Collular Biology, Salk Insistute, vol.
5, pp. 1111—1121 (1985).

Primary Examiner—Terry McKelvey
(74) Attorney, Agent, or Firm—Scully, Scott, Murphy &
Presser

(57)

ABSTRACT

Polynucleotides that comprise regulatory regions of the
yeast alcohol oxidase 1 promoter are provided. Isolated

polynucleotides, recombinant polynucleotides, vectors,
expression cassettes and transformed cells containing the
regulatory regions are disclosed. Proteins produced by the
transformed cells are also provided.
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ALCOHOL OXIDASE 1 REGULATORY

because its genome and physiology have been extensively
characteriZed. It is not alWays the optimal expression
system, hoWever, for the large-scale production of heterolo

NUCLEOTIDE SEQUENCES FOR
HETEROLOGOUS GENE EXPRESSION IN
YEAST

gous proteins because of plasmid loss during scale-up,
hyperglycosylation, and loW protein yields. Recently,
methylotrophic yeast expression systems have been devel

FIELD OF THE INVENTION

oped and offer several advantages over their counterpart, S.

cerevisiae. For example, methylotrophic yeast expression

The current invention is generally directed toward iso

lated polynucleotides comprising regulatory nucleotide
sequences, vectors and expression cassettes containing such
regulatory sequences, and host cells comprising the vectors
and/or expression cassettes. In particular, the invention
relates to 5‘ upstream regulatory nucleotide sequences
Within the promoter region of the alcohol oxidase 1 gene,
vectors and expression cassettes containing such regulatory
sequences, and host cells comprising the vectors and/or
expression cassettes.

10

In particular, the methylotrophic yeast, R pastoris, has
been extensively utiliZed for the production of heterologous
15

Which sequester this toxic byproduct from the rest of the
cell. Alcohol oxidase has a loW af?nity for its substrate,
oxygen. The partitioning of alcohol oxidase in the
peroxisome, therefore, serves the additional role of concen

20

In addition to the AOX1 gene, R pastoris also harbors a
second functional AOX gene, AOX2. AOX2 encodes a

protein that shares approximately 97% homology, and has
the same speci?c activity as its AOX1 counterpart. HoWever,
the 5‘ upstream regulatory regions of AOX1 and AOX2 do
30

not have signi?cant regions of homology, despite the fact
that both genes are repressed during groWth on glucose,

derepressed during carbon limitation, and induced by
groWth on methanol as the sole carbon source. In addition,
35

AOX2 induction is responsible for only 15% of total alcohol
oxidase activity in methanol-groWn cell cultures. Due to the
limited accumulation of AOX2 relative to AOX1, the AOX1
promoter is more advantageous to employ in an expression

system for large-scale protein production.
Although high-level expression of heterologous proteins
40

Well as their degradation. Synthesis of methanol metaboliZ

ing enZymes is induced by methanol, formaldehyde and
formate, and repressed by both glucose and ethanol. As

has been achieved employing the AOX1 promoter from R
pastoris, very little is knoWn about the molecular mecha
nisms involved in methanol induction, either in R pastoris

or methylotrophic yeasts in general. The promoter region for
AOX1 has been identi?ed (SEQ ID NO: 1), hoWever,
45

tively at the transcription level. Several genes encoding
alcohol oxidase from Pichia pastoris (AOX1 and AOX2),
Candida boidinii S2 (AOD1), and methanol oxidase from
Hansenula polymorpha (MOX1) are Well characteriZed.
Methanol induction causes the rapid de novo synthesis of

efficient and tightly regulated promoters knoWn. For

soluble protein.
25

trating the enZyme and substrate, thereby compensating, at

stated above, a key enZyme in methanol oxidation is alcohol
oxidase, Which is also controlled both positively and nega

regulated alcohol oxidase I gene and is one of the most

example, as delineated above, in methanol groWn R pastoris
cells, AOX rapidly accumulates up to 30% of the total

least in part, for its loW oxygen affinity.
The regulation of methanol metabolism in yeast generally
occurs at the level of transcription, and includes control of
the synthesis and activation of corresponding enZymes, as

suitable expression system for the production of proteins at
promoter, AOX1, used to drive gene expression. The AOX1
promoter, as stated above, is derived from the methanol

Hansenula and Pichia species. These yeast possess a con

peroxide toxicity, methanol metabolism is highly compart
mentaliZed in specialiZed organelles, called peroxisomes,

proteins at the industrial scale. R pastoris is a particularly
the industrial scale because of the presence of a unique

Torulopsis species, and the ascomycetous consisting of the
served methanol utiliZation pathWay. In the ?rst step of this
pathWay, the enZyme alcohol oxidase catalyZes the oxidation
of methanol to formaldehyde. Concomitantly, this reaction
also generates hydrogen peroxide, a substance that is highly
toxic to most cellular organelles. In order to avoid hydrogen

ity of methods, host strains, and expression vectors that

facilitate genetic manipulations.

BACKGROUND OF THE INVENTION

Methylotrophic yeast are capable of utiliZing methanol as
their sole energy source. The methylotrophic yeast comprise
tWo groups, the asporagenous consisting of the Candida and

systems achieve very high cell densities in a simple de?ned
medium, have strong inducible promoters, and the availabil

50

regulatory sequences Within this region have not been exten
sively characteriZed. See Stroman et al., US. Pat. No.

4,855,231. In addition, the promoter region for the AOX2
gene has also been identi?ed (SEQ ID NO: 2), and consists
of three cis-acting regulatory elements that have been char
acteriZed (one positive and the other tWo negative). See

alcohol oxidase, Which is accompanied by a corresponding

Cregg., US. Pat. No. 5,032,516. The positive cis-acting

increase in alcohol oxidase mRNA. For example, in metha
nol groWn R pastoris cells, AOX rapidly accumulates up to
30% of the total soluble protein.

element, the AOX2 upstream activator site, is required for a
response to transcriptional induction by methanol. The tWo

Yeasts have been extensively employed for the production
of heterologous proteins and offer several advantages over
prokaryotic expression systems. For example, some eukary
otic proteins that are produced in prokaryotic cells are either
unstable or lack biological activity. Accordingly, in these
cases, yeasts offer advantages over their prokaryotic coun
terparts Which include an intracellular environment that is
more conducive for correct folding of eukaryotic proteins.

Additionally yeasts, unlike prokaryotic hosts, have the abil
ity to glycosylate proteins, Which is important for both the
stability and biological activity of the protein.
Saccharomyces cerevisiae Was the ?rst, and remains the

most commonly employed eukaryotic expression system

negative cis-acting elements are responsible for repression
55

of the AOX2 promoter. HoWever, as delineated above, the 5‘
upstream regulatory regions of AOX1 and AOX2 do not

have signi?cant regions of homology and thus, the extensive
characteriZation of AOX2 regulation provides little insight
60

65

into the mechanism by Which the AOX1 promoter is regu
lated.
In yet a further attempt to characteriZe regulatory regions
of the AOX1 promoter, its sequence Was compared to the 5‘
upstream regulatory regions of an alcohol oxidase gene,
ZZA (SEQ ID NO: 3), isolated from an uncharacteriZed R

pastoris strain. See Kumagai et al., US. Pat. No. 5,641, 661.
This strain also contains tWo copies of the AOX genes. The
deduced amino acid sequence of ZZA revealed that 14 of the

US 6,699,691 B2
3
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?rst 16 amino acids are identical to that of the AOX1 and

taining a nucleotide sequence less than about 1000 nucle

AOX2 genes. However, similar to the 5‘ regulatory regions
of AOX1 and AOXZ, the 5‘ upstream regulatory regions of
ZZA and AOX1 share only 66% homology. The tWo

otides long selected from the group consisting of:
(a) SEQ ID NO: 19, a fragment of SEQ ID NO: 19, the

promoters, thus, may be regulated by completely distinct

complement of SEQ ID NO: 19;
(b) a polynucleotide that hybridiZes to the polynucleotide
of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).

complement of SEQ ID NO: 19, or a fragment of the

mechanisms.

Highly conserved nucleotide sequences,

(TTGNNNGCTTCCAANNNTGGT) (SEQ ID NO: 4) and
CCNCTTTTTG (SEQ ID NO: 5) have been found in the 5‘

?anking regions of alcohol oxidase, methanol oxidase, and
dihydroxyacetone synthase genes in R pastoris, H. poly

In yet a further aspect of the invention is provided an

isolated polynucleotide comprising a regulatory region con

morpha and C. boia'ini S2. See Kumagai et al., US. Pat. No.
5,641,661. It Was postulated that these conserved regions

taining a nucleotide sequence less than about 1000 nucle

otides long selected from the group consisting of:
(a) SEQ ID NO: 20, a fragment of SEQ ID NO: 20, the

Were involved in binding methanol-speci?c trans-acting
factors. HoWever, in a study characteriZing the AOX2

complement of SEQ ID NO: 20, or a fragment of the

promoter, these sequences Were not involved in transcrip
tional regulation of the AOX2 gene since deletion of these

complement of SEQ ID NO: 20;
(b) a polynucleotide that hybridiZes to the polynucleotide
of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).

regions did not impact regulation of the AOX2 promoter
(Ohi, et al. (1994) Mol.Gen Genet 243:489—99). Thus,
although these regions may be highly conserved across
methylotrophic yeasts, their impact on transcriptional regu

A further aspect of the invention provides an isolated

lation of the AOX genes remains to be fully elucidated.
Accordingly, a need exists to identify promoters and other
regulatory nucleotide sequences for the controlled expres

sion and/or high level expression of heterologous proteins in

polynucleotide comprising a regulatory region containing a
25

yeast. In particular, a need exists to provide neW AOX1
promoters and regulatory nucleotide sequences for the con

trolled expression and/or high level expression of heterolo
gous proteins in yeast.

nucleotide sequence less than about 1000 nucleotides long
selected from the group consisting of:
(a) SEQ ID NO: 21, a fragment of SEQ ID NO: 21, the
complement of SEQ ID NO: 21, or a fragment of the
complement of SEQ ID NO: 21;

(b) a polynucleotide that hybridiZes to the polynucleotide
of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).

SUMMARY OF THE INVENTION

Among the several aspects of the invention therefore is

provided an isolated polynucleotide comprising a regulatory

Still another aspect of the invention provides a recombi
nant vector comprising the polynucleotide of SEQ ID NO:
16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ
ID NO: 20, and SEQ ID NO: 21. Host cells comprising the

region containing a nucleotide sequence less than about
1000 nucleotides long selected from the group consisting of:
(a) SEQ ID NO: 16, a fragment of SEQ ID NO: 16, the
complement of SEQ ID NO: 16, or a fragment of the

recombinant vector are also provided.

complement of SEQ ID NO: 16;
(b) a polynucleotide that hybridiZes to the polynucleotide
of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).

A further aspect provides an expression cassette compris
ing the polynucleotide of SEQ ID NO: 16, SEQ ID NO: 17,
SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ
ID NO: 21. Host cells comprising the expression cassette are

also provided.

Another aspect provides an isolated polynucleotide com

prising a regulatory region containing a nucleotide sequence
less than about 1000 nucleotides long selected from the
group consisting of:
(a) SEQ ID NO: 17, a fragment of SEQ ID NO: 17, the
complement of SEQ ID NO: 17, or a fragment of the
complement of SEQ ID NO: 17;
(b) a polynucleotide that hybridiZes to the polynucleotide

BRIEF DESCRIPTION OF THE DRAWINGS
45

panying ?gures Where:
FIG. 1 depicts the construction of expression vector,
pAL2 and mutagenesis vector pMMI101. PAL2 Was con

of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).
In yet another aspect is provided an isolated polynucle
otide comprising a regulatory region containing a nucleotide
sequence less than about 1000 nucleotides long selected
from the group consisting of:
(a) SEQ ID NO: 18, a fragment of SEQ ID NO: 18, the
complement of SEQ ID NO: 18, or a fragment of the
complement of SEQ ID NO: 18;
(b) a polynucleotide that hybridiZes to the polynucleotide

of (a) under conditions of high stringency; and
(c) a polynucleotide With at least 80% sequence homology
to the polynucleotide of (a).
Still another aspect of the invention is provided an iso
lated polynucleotide comprising a regulatory region con

These and other features, aspects, and advantages of the
present invention Will become better understood With regard
to the folloWing description, appended claims, and accom

structed by inserting Eco RI/Sma I fragment of pSAOHS
into pIB1 promoterless vector. The vector pMMI101 Was
55

constructed by inserting Eco RI/Bam HI fragment of
pSAOHS into Eco RI/Bam.
FIG. 2 depicts deletion analysis of the AOX1 promoter.
The plasmids Were inserted into GS115 his4 locus. Single
copy integrands Were identi?ed by Southern assay using
HIS4 gene as a probe. The cells Were groWn in MM

m0

(induced) and MME (repressed) conditions. [3-Gal activity
of the AOX1-lacZ fusion Was measured and reported as

percent of activity of methanol-groWn cells containing
pAL2. The TATA box is indicated by the black square, and
+1 AT G is indicated by the upside doWn, black triangle.
FIG. 3 depicts results of the gel shift assay for fragment

A(SEQ ID NO: 16). Lane 1, no protein added; lane 2—5, six
mg protein from MM groWn cells; lane 6, six mg protein

US 6,699,691 B2
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from MME grown cells; lane 3, thirty fold cold speci?c
DNA (fragmentA(SEQ ID NO: 16)); lane 4, thirty fold cold
fragment C (SEQ ID NO: 18); lane 5 thirty fold L. mono

etc.), as Well as unmodi?ed forms of the polynucleotide.
Polynucleotides include both sense and antisense strands.
As used herein, “sequence” means the linear order in
Which monomers occur in a polymer, for example, the order
of amino acids in a polypeptide or the order of nucleotides
in a polynucleotide.
As used herein, the terms “complementary” or “comple

cytogeneses DNA.
FIG. 4 depicts results of the gel shift assay for fragment

C (SEQ ID NO: 18). Lane 1, no protein added; lanes 2—5,
protein from MM groWn cells; lanes 7—9, protein from MME
groWn cells; lane 3 and 7, thirty fold cold speci?c competitor
(fragment C (SEQ ID NO: 18)); lanes 4 and 6, thirty fold

cold unspeci?c competitor (fragment A (SEQ ID NO: 16));

mentarity” refer to the pairing of bases, purines and

pyrimidines, that associate through hydrogen bonding in
10

double stranded nucleic acid. The folloWing base pairs are

lanes 5 and 9, thirty fold cold unspeci?c L. monocytogenes

complementary: guanine and cytosine; adenine and thym

DNA.

ine; and adenine and uracil. The terms as used herein include

FIG. 5 depicts results of the gel shift assay for fragment
F (SEQ ID NO: 21). Lane 1, no protein added; lane 2, six mg
protein from MM groWn cells; lane 3, tWelve mg protein
from MM groWn cells; lane 4, six mg protein from MME
groWn cells; lane 5, tWelve mg protein from MME groWn

complete and partial complementarity.
15

As used herein, the term “hybridization” refers to a
process in Which a strand of nucleic acid joins With a

complementary strand through base pairing. The conditions

cells.
FIG. 6 depicts the consensus sequences of methanol

employed in the hybridiZation of tWo non-identical, but very
similar, complementary nucleic acids varies With the degree
of complementarity of the tWo strands and the length of the

regulated promoters of methylotrophic yeast. Occurrence of

strands. Thus the term contemplates partial as Well as

TTCCAA (A) (Kumagai et al., 1993) and GATAG (B) (Ohi

complete hybridiZation. Such techniques and conditions are

et al., 1994) core consensus sequence in AOX1 promoter. C,
Alignment of the MOX UAS2 With AOX1 promoter

Well knoWn to practitioners in this ?eld.
As used herein, “expression cassette” means a genetic
module comprising a gene and the regulatory regions nec
essary for its expression, Which may be incorporated into a

(Godecke et al., 1994). Minus numbers are given relative to
+1 ATG codon, +/— de?nes plus/minus strand. The fragment
letters containing the sequences are also given in the right

25

vector.

column.

As used herein, “secretion sequence” or “signal peptide”
or “signal sequence” means a sequence that directs neWly

ABBREVIATIONS AND DEFINITIONS

synthesiZed secretory or membrane proteins to and through
membranes of the endoplasmic reticulum, or from the cyto
plasm to the periplasm across the inner membrane of
bacteria, or from the matrix of mitochondria into the inner
space, or from the stroma of chloroplasts into the thylakoid.

To facilitate understanding of the invention, a number of
terms and abbreviations as used herein are de?ned beloW:

As used herein “isolated polynucleotide” means a poly
nucleotide that is free of one or both of the nucleotide

sequences Which ?ank the polynucleotide in the naturally
occurring genome of the organism from Which the poly

35

nucleotide is derived. The term includes, for example, a
polynucleotide or fragment thereof that is incorporated in a
vector or expression cassette; into an autonomously repli
cating plasmid or virus; into the genomic DNA of a prokary

protein from the host cell.
As used herein, “operably linked” means any linkage,
irrespective of orientation or distance, betWeen a regulatory
sequence and coding sequence, Where the linkage permits
the regulatory sequence to control expression of the coding

ote or eukaryote; or that exists as a separate molecule

independent of other polynucleotides. It also includes a
recombinant chimeric polynucleotide that is part of a hybrid
polynucleotide, for example, one encoding a polypeptide
sequence.

sequence.

As used herein, “heterologous coding sequence” means
45

As used herein “polynucleotide” and “oligonucleotide”
are used interchangeably and refer to a polymeric (2 or more

region” as used in reference to a speci?c gene refers to the

coding or non-coding nucleotide sequences Within that gene
that are necessary or suf?cient to provide for the regulated
expression of the coding region of a gene. Thus, the term

backbone linkages composed of aminoethyl glycine units.

encompasses promoter sequences, regulatory protein bind
ing sites, upstream activator sequences and the like. Speci?c
55

modi?cations, for example, labels, methylation, “caps”,
substitution of one or more of the naturally occurring
nucleotides With an analog, internucleotide modi?cations

nucleotides Within a regulatory region may serve multiple
functions. For example, a speci?c nucleotide may be part of
a promoter and participate in the binding of a transcriptional

activator protein.
As used herein, “coding region” refers to that portion of

such as, for example, those With uncharged linkages (e.g.,

a gene Which codes for a protein. The term “non-coding
region” refers to that portion of a gene that is not a coding

methyl phosphonates, phosphotriesters, phosphoamidates,
carbamates, etc.), those containing pendant moieties, such

region.

as, for example, proteins (including for e.g., nucleases,

toxins, antibodies, signal peptides, poly-L-lysine, etc.),
those With intercalators (e.g., acridine, psoralen, etc.), those
containing chelators (e.g., metals, radioactive metals, boron,
oxidative metals, etc.), those containing alkylators, those
With modi?ed linkages (e.g., alpha anomeric nucleic acids,

any coding sequence other than the one that naturally
encodes the alcohol oxidase 1 protein, or any homolog of the
alcohol oxidase 1 protein.

As used herein, “regulatory sequence” or “regulatory

monomers) form of nucleotides of any length, either ribo
nucleotides or deoxyribonucleotides. Although nucleotides
are usually joined by phosphodiester linkages, the term also
includes polymeric nucleotides containing neutral amide
This term refers only to the primary structure of the mol
ecule. Thus, this term includes double- and single-stranded
DNA and RNA. It also includes knoWn types of

Fusion of such a sequence to a gene that is to be expressed
in a heterologous host ensures secretion of the recombinant

65

DESCRIPTION OF THE PREFERRED
EMBODIMENTS

Applicants have identi?ed regulatory nucleotide
sequences that are part of the non-coding region of the

US 6,699,691 B2
7

8

alcohol oXidase 1 (“AOX1”) gene. The AOX1 gene encodes
the enzyme alcohol oXidase 1, Which catalyzes the oxidation
of methanol to formaldehyde (as stated in more detail
above). The AOX1 promoter, is an inducible promoter, and

fragment) is less than about 1000 nucleotides long, in
another embodiment the polynucleotide is betWeen about 4
nucleotides to about 750 nucleotides long. More preferably,
hoWever, the polynucleotide is betWeen about 250 nucle
otides to about 750 nucleotides long. The fragments may be

is primarily induced by methanol and carbon starvation, and
repressed in response to glucose and ethanol. Although the
AOX1 promoter has been identi?ed (SEQ ID NO: 1), prior
to applicants discovery, 5‘ regulatory nucleotide sequences
Within the promoter region had not been characteriZed. The
regulatory regions discovered by applicants, as set-forth
herein, may be employed to increase the eXpression of genes

10

employed as probes for SEQ ID NO: 17 or related
sequences. Also included are isolated polynucleotides that
hybridiZe to SEQ ID NO: 17, or the complement of SEQ ID
NO: 17 under conditions of high stringency. In one embodi
ment these polynucleotides are less than about 1000 nucle

otides long, in another embodiment these polynucleotides

of interest in a variety of cells.

are betWeen about 4 nucleotides to about 750 nucleotides

In order to identify the regulatory regions of the present
invention, applicants divided the 1052 base pair AOX1
promoter (SEQ ID NO: 1) into siX fragments, A (SEQ ID
NO: 16), B (SEQ ID NO: 17), C (SEQ ID NO: 18), D (SEQ
ID NO: 19), E (SEQ ID NO: 20), and F (SEQ ID NO: 21).
Through a series of systematic deletions comprising both

long. Such polynucleotides may be used as probes for SEQ

sequential deletions and dropout mutations, in conjunction
With gel shift assays, regions of the AOX1 promoter (SEQ

ID NO: 17 or related sequences.
15

complement of SEQ ID NO: 18, or a fragment of the
complement of SEQ ID NO: 18. In one embodiment the
20

ID NO: 1) element involved in regulation and DNA-protein

is betWeen about 4 nucleotides to about 750 nucleotides

long. More preferably, hoWever, the polynucleotide is
25

NO: 18 or related sequences. Also included are isolated

polynucleotides that hybridiZe to SEQ ID NO: 18, or the
complement of SEQ ID NO: 18 under conditions of high
30

35

An additional embodiment provides an isolated poly

40

The present invention, therefore, encompasses an isolated

polynucleotide comprising a regulatory region containing
SEQ ID NO: 16, a fragment of SEQ ID NO: 16, the
complement of SEQ ID NO: 16, or a fragment of the
complement of SEQ ID NO: 16. In one embodiment the

nucleotides may be used as probes for SEQ ID NO: 18 or
related sequences.

nucleotide comprising a regulatory region containing SEQ

ID NO: 21) contain positive regulatory sites, and fragment
D (SEQ ID NO: 19) contains a negative regulatory site, in
addition to the stated function, each of these regulatory
regions may serve multiple regulatory functions.

stringency (as de?ned herein). In one embodiment these
polynucleotides are less than about 1000 nucleotides long, in
another embodiment these polynucleotides are betWeen
about 4 nucleotides to about 750 nucleotides. Such poly

may serve multiple functions. For example, a speci?c nucle
otide may be part of a promoter and participate in the

binding of a transcriptional activator protein. Thus, While
applicants believe that A(SEQ ID NO: 16), B (SEQ ID NO:
17), C (SEQ ID NO: 18), E (SEQ ID NO: 20), and F (SEQ

betWeen about 250 nucleotides to about 750 nucleotides

long. The fragments may be employed as probes for SEQ ID

regulatory site. In addition, based upon gel shift assays, as
depicted in FIG. 3 and FIG. 4, it is believed that fragments

A (SEQ ID NO: 16), and C (SEQ ID NO: 18) contain
sequences for different DNA-binding proteins. It should be
noted that, speci?c nucleotides Within a regulatory region

polynucleotide (or the fragment, or the complement of either
the polynucleotide or fragment) is less than about 1000
nucleotides long, in another embodiment the polynucleotide

interactions Were identi?ed (as set-forth in more detail in the

eXample section beloW). Based upon this deletion analysis,
as depicted in FIG. 2, fragments A (SEQ ID NO: 16), B
(SEQ ID NO: 17), C (SEQ ID NO: 18), E (SEQ ID NO: 20),
and F (SEQ ID NO: 21) contain positive regulatory sites,
While fragment D (SEQ ID NO: 19) contains a negative

In yet another embodiment, the invention encompasses an

isolated polynucleotide comprising a regulatory region con
taining SEQ ID NO: 18, a fragment of SEQ ID NO: 18, the

45

polynucleotide (or the fragment, or the complement of either

ID NO: 19, a fragment of SEQ ID NO: 19, the complement
of SEQ ID NO: 19, or a fragment of the complement of SEQ
ID NO: 19. In one embodiment the polynucleotide (or the
fragment, or the complement of either the polynucleotide or
fragment) is less than about 1000 nucleotides long, in
another embodiment the polynucleotide is betWeen about 4
nucleotides to about 750 nucleotides long. More preferably,
hoWever, the polynucleotide is betWeen about 250 nucle
otides to about 750 nucleotides long. The fragments may be

long. More preferably, hoWever, the polynucleotide is

employed as probes for SEQ ID NO: 19 or related
sequences. Also included are isolated polynucleotides that
hybridiZe to SEQ ID NO: 19, or the complement of SEQ ID
NO: 19 under conditions of high stringency. In one embodi
ment these polynucleotides are less than about 1000 nucle

betWeen about 250 nucleotides to about 750 nucleotides

otides long, in another embodiment these polynucleotides

the polynucleotide or fragment) is less than about 1000

nucleotides long, in another embodiment the polynucleotide
is betWeen about 4 nucleotides to about 750 nucleotides

50

long. The fragments may be employed as probes for SEQ ID

are betWeen about 4 nucleotides to about 750 nucleotides.

NO: 16 or related sequences. Also included are isolated

Such polynucleotides may be used as probes for SEQ ID

polynucleotides that hybridiZe to SEQ ID NO: 16, or the
complement of SEQ ID NO: 16 under conditions of high
stringency. In one embodiment these polynucleotides are
less than about 1000 nucleotides long, in another embodi

55 NO: 19 or related sequences.

In yet another embodiment, the invention encompasses an

isolated polynucleotide comprising a regulatory region con
taining SEQ ID NO: 20, a fragment of SEQ ID NO: 20, the

ment these polynucleotides are betWeen about 4 nucleotides

to about 750 nucleotides long. Such polynucleotides may be

60

used as probes for SEQ ID NO: 16 or related sequences.

polynucleotide (or the fragment, or the complement of either

Still another embodiment provides an isolated polynucle

the polynucleotide or fragment) is less than about 1000
nucleotides long, in another embodiment the polynucleotide

otide comprising a regulatory region containing SEQ ID
NO: 17, a fragment of SEQ ID NO: 17, the complement of
SEQ ID NO: 17, or a fragment of the complement of SEQ
ID NO: 17. In one embodiment the polynucleotide (or the
fragment, or the complement of either the polynucleotide or

complement of SEQ ID NO: 20, or a fragment of the
complement of SEQ ID NO: 20. In one embodiment the

is betWeen about 4 nucleotides to about 750 nucleotides
65

long. More preferably, hoWever, the polynucleotide is
betWeen about 250 nucleotides to about 750 nucleotides

long. The fragments may be employed as probes for SEQ ID

US 6,699,691 B2
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NO: 20 or related sequences. Also included are isolated

empirically in preliminary experiments, but usually involve

polynucleotides that hybridize to SEQ ID NO: 20, or the
complement of SEQ ID NO: 20 under conditions of high
stringency. In one embodiment these polynucleotides are
less than about 1000 nucleotides long, in another embodi

a combination of salt and temperature that is approximately

12—20° C. beloW the Tm. One example of high stringency
conditions is 1><SSC at 60° C. Another example of high
stringency Wash conditions is 0.1><SSPE, 0.1% SDS at 42°

ment these polynucleotides are betWeen about 4 nucleotides

C. (Meinkoth and Wahl, Anal. Biochem., 138:267—284,
1984). An example of even higher stringency Wash condi

to about 750 nucleotides long. Such polynucleotides may be
used as probes for SEQ ID NO: 20 or related sequences.

tions is 0.1><SSPE, 0.1% SDS at 50—65° C. In one preferred

A further embodiment of the present invention provides
an isolated polynucleotide comprising a regulatory region
containing SEQ ID NO: 21, a fragment of SEQ ID NO: 21,
the complement of SEQ ID NO: 21, or a fragment of the

embodiment, high stringency Washing is carried out under
10

conditions of 1><SSC and 60° C.
In another embodiment, the present invention provides an
isolated polynucleotide sequence With at least 80%, more
preferably 90%, more preferably still 95%, even more
preferably 97% and still more preferably 99% sequence

15

homology to SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO:

complement of SEQ ID NO: 21. In one embodiment the

polynucleotide (or the fragment, or the complement of either
the polynucleotide or fragment) is less than about 1000

nucleotides long, in another embodiment the polynucleotide

18, SEQ ID NO: 19, SEQ ID NO: 20, or SEQ ID NO 21 or

is betWeen about 4 nucleotides to about 750 nucleotides

the complement of SEQ ID NO: 16, SEQ ID NO: 17, SEQ

long. More preferably, hoWever, the polynucleotide is

ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, or SEQ ID NO

betWeen about 250 nucleotides to about 750 nucleotides

long. The fragments may be employed as probes for SEQ ID

20

NO: 21 or related sequences. Also included are isolated

polynucleotides that hybridiZe to SEQ ID NO: 21, or the
complement of SEQ ID NO: 21 under conditions of high
stringency. In one embodiment these polynucleotides are
less than about 1000 nucleotides long, in another embodi

or more polynucleotide sequences, as determined by com

25

ment these polynucleotides are betWeen about 4 nucleotides

of the hybrid formed. The Tm (melting temperature) of a

30

nucleic acid hybrid is the temperature at Which 50% of the

In this case, the Tm re?ects a time-independent equilibrium
that depends on the concentration of oligonucleotide. In
contrast, if both strands are longer, the Tm corresponds to a

A. M. and Grif?n, H. G., eds., Humana Press, NeW Jersey
(1994); Sequence Analysis in Molecular Biology, von
35

NeW York (1991); and Carillo, H., and Lipman, D., SIAMJ
Applied Math, 48:1073 (1988). Methods to determine
homology are designed to give the largest match betWeen the

situation in Which the strands are held together in structure
40

equilibrium that is independent of time and polynucleotide
concentration.
As is also Well knoWn in the art, Tm is dependent on the

composition of the polynucleotide (e.g. length, type of
duplex, base composition, and extent of precise base
pairing) and the composition of the solvent (e.g. salt con
centration and the presence of denaturants such formamide).

(Devereux, J., et al., Nucleic Acids Research 12(1):387
45

(1984); suite of ?ve BLAST programs, three designed for

nucleotide sequences queries (BLASTN, BLASTX, and
TBLASTX) and tWo designed for protein sequence queries
(BLASTP and TBLASTN) (Coulson, Trends in
Biotechnology, 12: 76—80 (1994); Birren, et al., Genome

Sambrook et al. (Molecular Cloning, 2nd ed., Cold Spring
Harbor Press, 1989) and is:

50

Where L is the length of the hybrid in base pairs, the

55

Analysis, 1: 543—559 (1997)). The BLAST X program is
publicly available from NCBI and other sources (BLAST
Manual, Altschul, S., et al., NCBI NLM NIH, Bethesda, Md.
20894; Altschul, S., et al., J. Mol. Biol., 215:403—410
(1990)). The Well knoWn Smith Waterman algorithm can
also be used to determine homology.

The isolated polynucleotide comprising the regulatory
region of the present invention, Without being bound by any
particular limitation, may comprise any combination of SEQ

concentration of Na+ is in the range of 0.01M to 0.4M and
the G+C content is in the range of 30% to 75%. Equations
for hybrids involving RNA can be found in the same
reference. Alternative equations can be found in Davis et al.,
60

ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO:
19, SEQ ID NO: 20, and SEQ ID NO: 21 or a fragment of

any of these sequences. Additionally, the regulatory region
may comprise any combination of the complement of SEQ
ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO:

Methods for hybridiZation and Washing are Well knoWn in
the art and can be found in standard references in molecular

biology such as those cited herein. In general, hybridiZations
are usually carried out in solutions of high ionic strength
(6><SSC or 6><SSPE) at a temperature 20—25° C. beloW the
Tm. High stringency Wash conditions are often determined

sequences tested. Moreover, methods to determine homol
ogy are codi?ed in publicly available programs. Computer
programs Which can be used to determine identity/homology
betWeen tWo sequences include, but are not limited to, GCG

An equation for the calculation of Tm can be found in

Basic Methods in Molecular Biology, 2nd ed., Appleton and
Lange, 1994, Sec 6—8.

Heinje, G., Academic Press (1987); Sequence Analysis
Primer, Gribskov, M. and Devereux, J ., eds., Stockton Press,

possibly containing alternating duplex and denatured
regions. In this case, the Tm re?ects an intramolecular

Biology, Lesk, A. M., ed., Oxford University Press, NeW
York (1988); Biocomputing: Informatics and Genome
Projects, Smith, D. W., ed., Academic Press, NeW York,

1993,‘ Computer Analysis of Sequence Data, Part I, Griffin,

bases are base-paired. For example, if one the partners in a

hybrid is a short oligonucleotide of approximately 20 bases,
50% of the duplexes are typically strand separated at the Tm.

paring the sequences. In the art, “homology” also means the
degree of sequence relatedness betWeen polypeptide or
polynucleotide sequences, as determined by the match
betWeen strings of such sequences. “Homology” can be

readily calculated by knoWn methods including, but not
limited to, those described in Computational Molecular

to about 750 nucleotides long. Such polynucleotides may be
used as probes for SEQ ID NO: 21 or related sequences.

As is Well knoWn in the art, stringency is related to the Tm

21.
“Homology”, as is Well understood in the art, is a rela
tionship betWeen tWo or more polypeptide sequences or tWo

19, SEQ ID NO: 20, and SEQ ID NO: 21 or a fragment of
65

the complement of any of these sequences. The regulatory
region, may also comprise any combination of isolated

polynucleotides that hybridiZe under conditions of high

US 6,699,691 B2
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Expression and cloning vectors can and usually do con

stringency to SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO:
18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO: 21
or that hybridize under conditions of high stringency to the
complement of SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID
NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ ID NO:

tain a selection gene or selection marker. Typically, this gene
encodes a protein necessary for the survival or groWth of the

host cell transformed With the vector. Examples of suitable

selection markers include, HIS4, ARG4, ble, and kan (Cregg
et al., (2000) Mol. Biotech. 16: 23—52). The selection marker

21. Furthermore, the regulatory region, may comprise any
combination of isolated polynucleotides With at least 80%
sequence homology to SEQ ID NO: 16, SEQ ID NO: 17,
SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, and SEQ
ID NO: 21 or the complement of SEQ ID NO: 16, SEQ ID
NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20,
and SEQ ID NO: 21. Accordingly, for example, in one

can have its oWn promoter so that expression of the marker

occurs independent of the polynucleotide construct. The
marker promoter can be either a constitutive or an inducible
10

embodiment of the present invention, the regulatory region
comprises SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO:
18, from 1 to about 3 copies of SEQ ID NO: 20, and SEQ
ID NO: 21. In yet another embodiment, the regulatory
region comprises SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID
NO: 20, and SEQ ID NO: 21.

hybridiZation of a probe to a genomic library to detect shared
nucleotide sequence and is detailed in, for example, Sam
brook et al., Molecular Cloning, A Laboratory Manual, 2nd

mosome by homologous recombination. Preferably, the
homologous sequence employed in the invention Will be at
least approximately 200 nucleotides in length and have
homology to yeast genomic DNA. Applicants have found
that such integration is desirable, particularly When the host

20

is P pastoris, because vectors that are not integrated tend to
be unstable.
More particularly, in another embodiment is provided a

recombinant polynucleotide comprising any of the above
described regulatory regions of the invention operably
25

ed., Cold Spring Harbor Laboratory Press, (1989) and
Ausubel et al., Short Protocols in Molecular Biology, 3rd

ed., John Wiley & Sons (1995).
Also included are vectors comprising the isolated poly
nucleotide regulatory sequences of the invention or the
complement thereof, as set-forth in detail above. Any vector

In a further embodiment, the vector of the present inven
tion also typically Will include a sequence that is homolo
gous With the host’s sequence at a particular gene loci, for
example a portion of the His4 gene or AOX gene (both yeast
genes), to enable the vector to insert into the host’s chro

15

The polynucleotides comprising regulatory regions of the
present invention may be isolated by any method generally
knoWn in the art for isolating non-coding regions of nucleic
acid sequence. One such method comprises employing

promoter.

30

linked to a heterologous coding region. Such recombinant
polynucleotides are commonly employed in cloning or
expression vectors (as detailed above), although other uses
are possible. The heterologous coding region may encode
any protein of interest suitable for expression in the host cell
such as enZymes, hormones, regulatory proteins, structural
proteins, or antigens (for use in inducing an immune

suitable for propagation in yeast may be employed such as,

response).

for example, pIB1 (Sears et al., (1998) Yeast 14: 783—90),
pPICZ (commercially available through Invitrogen,
Carlsbad, Calif.) vector series, and pPIC9K (commercially
available through Invitrogen, Carlsbad, Calif.). The vector

The isolated polynucleotides of the present invention may
be part of an expression cassette that minimally comprises,
35

operably linked in 5‘ to 3‘ direction, a polynucleotide com

prising a regulatory region of the present invention, a

may also be either a cloning vector or an expression vector.

heterologous coding region and a transcriptional termination

A cloning vector is a self-replicating DNA molecule that

signal sequence functional in a host cell. The expression
cassette may comprise any of the isolated polynucleotide

serves to maintain a DNA segment into a host cell. The most

common type of cloning vectors are bacterial plasmids. An
expression vector is a cloning vector designed so that a
sequence inserted at a particular site Will be transcribed into
mRNA and in addition may be translated into a protein. Both

40

regulatory regions of the invention, as previously discussed.

Additionally, the heterologous coding region may encode

cloning and expression vectors usually contain nucleotide

any protein of interest suitable for expression in the host cell
such as enZymes, hormones, regulatory proteins, structural
proteins, or antigens (for use in inducing an immune

sequences that alloW the vectors to replicate in one or more 45

response).

suitable host cells. In cloning vectors, this sequence is
generally one that enables the vector to replicate indepen
dently of the host cell chromosomes, and also includes either

comprise an operably linked targeting sequence, transit or

secretion peptide coding region capable of directing trans

origins of replication or autonomously replicating
sequences. Various bacterial and yeast origins of replication

port of the protein produced to the desired location. The
expression cassette may also further comprise a nucleotide

In a further embodiment, the expression cassette can also

50

sequence encoding a selectable marker and/or a puri?cation
moiety. Various methods have been devised for the addition

are Well knoWn to those skilled in the art and include, but are

not limited to, the pBR322 plasmid origin, and the 2
uplasmid origin. Ausubel et al., ed., Short Protocols in
Molecular Biology, 3rd ed., Wiley & Sons, 1995.

The isolated polynucleotide comprising regulatory

of such af?nity puri?cation moieties to proteins. Represen
tative examples can be found in US. Pat. Nos. 4,703,004,
55

4,782,137, 4,845,341, 5,935,824, and 5,594,115. Any

sequences of the present invention may be inserted into the
vector by a variety of methods. In yet a further embodiment,

method knoWn in the art for the addition of nucleotide
sequences encoding puri?cation moieties can be used for

the isolated polynucleotide comprising regulatory regions

example those contained in Innis et al., PCR Protocols,
Academic Press (1990) and Sambrook et al., Molecular

operably linked to a heterologous coding region may be
inserted into the vector. In the most common method, the
sequence is inserted into an appropriate restriction endonu

60

clease site(s) using procedures commonly knoWn to those

Cloning, 2nd ed., Cold Spring Harbor Laboratory Press
(1989). In yet another embodiment, the expression cassette
can comprise a sequence that is homologous With the host’s

skilled in the art and detailed in, for example, Sambrook et

sequence at a particular gene loci to enable the cassette to

al., Molecular Cloning, A Laboratory Manual, 2nd ed., Cold
Spring Harbor Laboratory Press, (1989) and Ausubel et al.,
Short Protocols in Molecular Biology, 3rd ed., John Wiley &

insert into the host’s chromosome by homologous recom
bination.
Encompassed Within the present invention are host cells

Sons (1995).

transformed With any of the constructs described herein

65
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comprising the polynucleotide regulatory sequences of the

the sh ble gene is Widely used as a maker for

invention. The host cell is preferably a yeast cell. Yeast are
preferred hosts because their usage provides a means to

co-ampli?cation. The sh ble gene product confers resistance
to the drug Zeocin in both E. coli and yeast.
Proteins recovered can be puri?ed by a variety of com
monly used methods, including, but not limited to, ammo
nium sulfate precipitation, immuno precipitation, ethanol or

regulate gene expression When the regulatory sequences of
the invention are employed. As stated above, the regulatory
regions of the invention are repressible in response to

acetone precipitation, acid extraction, ion exchange

repressing carbon sources (eg glucose, ethanol, fructose,
galactose, sucrose and glycerol) and inducible in response to

chromatography, siZe exclusion chromatography, affinity

non-repressing carbon sources (eg sorbital, mannitol,
threhalose, and alanine) When subjecting the transformed

electrophoresis, and ultra ?ltration. If required, protein

chromatography, high performance liquid chromatography,
10

yeast to carbon starvation. Accordingly, gene expression can
be strictly regulated based upon the medium selected to
groW the cells.
Even more preferably, hoWever, the host Will be a methy

lotrophic yeast cell. Still more preferably, the methy
lotrophic yeast cell is selected from the group of genera

15

Even more preferably, the yeast cell is from R pastoris. The
use of methylotrophic yeast provides an additional means to

control gene expression When employing the regulatory
regions of the invention. Methylotrophic yeast, as opposed

host cells. HoWever, applicants discovery, in addition to

peroxisome biogenesis.

25

R pastoris cells, AOX rapidly accumulates up to 30% of the
total soluble protein. Thus, the use of methylotrophic yeast

The detailed description set-forth above is provided to aid
those skilled in the art in practicing the present invention.
Even so, this detailed description should not be construed to
unduly limit the present invention as modi?cations and
variation in the embodiments discussed herein can be made

by those of ordinary skill in the art Without departing from
the spirit or scope of the present inventive discovery.

as host cells in the present invention provides a mechanism
to both reliably control gene expression and at the same
time, achieve a high rate of expression. Introduction of the
construct into the host cell can be accomplished by any
method knoWn in the art.

All publications, patents, patent applications and other
references cited in this application are herein incorporated
by reference in their entirety as if each individual
publication, patent, patent application or other reference
Were speci?cally and individually indicated to be incorpo

The present invention also includes methods for the
production of proteins from the above described host cells
transformed With any of the constructs characteriZed herein

the invention, as described in detail above, may be employed
to increase the expression of genes of interest in a variety of
increased gene expression, may also be employed for a
number of other functions. For example, the regulatory
sequences of the invention may be employed in a research
setting to further characteriZe promoter function and to study

consisting of Hansenula, Candida, Torulopsis and Pichia.

to yeast in general, are capable of groWth on methanol as
their sole carbon and energy source. In addition, as delin
eated above, methanol is a strong inducer of the regulatory
sequences of the invention. For example, in methanol groWn

refolding systems can be used to complete the con?guration
of the protein.
The polynucleotide encoding the regulatory sequences of

rated by reference.
35

containing the polynucleotide regulatory regions of the
present invention operably linked to a gene encoding the
desired protein. Proteins can be expressed in any suitable
host cells, but are preferably expressed in yeast host cells for
the reasons previously identi?ed. Host cells are genetically

Without further elaboration, it is believed that one skilled

in the art can, using the preceding description, utiliZe the
present invention to its fullest extent. The folloWing pre
ferred speci?c embodiments are, therefore, to be construed
as merely illustrative, and not imitative of the remainder of
the disclosure in any Way Whatsoever.

transformed to produce the protein of interest by introduc

EXAMPLE

Materials and Methods
Strains and Plasmids.

tion of an expression vector containing the nucleic acid
sequence of interest. The characteristics of suitable cloning
vectors and the methods for their introduction into host cells

have been previously discussed. Methods for such protein

45

production are knoWn to those skilled in the art. (Davis et al.,
Basic Methods in Molecular Biology, Elsevier Science Pub

Plasmid pSAOH5 (Tschopp et al., (1987) Nucleic Acids
Res. 15: 3859—76) and R pastoris GS115 (Tschopp et al.,
(1987) Nucleic Acids Res. 15 : 3859—76) (his4) strain Were
the generous gift of J. M. Cregg, Keck Graduate Institute,
Claremont, Calif. pIB1 promoter less expression vector Was

lishing (1986); Ausubel et al., Short Protocols in Molecular

provided by B. S. Glick (University of Chicago, Chicago,
111.). E. coli strains JM109 (endA1, recA1, gyrA96, thi,

Biology, 2”d Ed., John Wiley & Sons (1992)).
Host cells are groWn under appropriate conditions to a

suitable cell density to optimiZe expression of the protein. If

hsdR17(rk_, mk+), relA1, supE44, l', D(lac_proAB), [F‘,

the protein accumulates in the host cell, the cells are

traD36, proA+B+, lacIqZDM15] and ES1301 mutS (LacZ53,

harvested by, for example, centrifugation or ?ltration. The

mutS201::Tn5, thyA36, rha'5, metB1, deoC,IN (rrnD-rrnE),

cells are then disrupted by physical or chemical means to
release the protein into the cell extract from Which the

pALTER®-1 plasmid Were purchased as a components of
55

protein can be puri?ed. If the host cells secrete the protein
into the medium, the cells and medium are separated and the
medium retained for puri?cation of the protein.
Larger quantities of protein can be obtained from cells
carrying ampli?ed copies of the sequence of interest. In this

Altered Sites® II in vitro Mutagenesis System (Promega,

Madison, Wis.).
Media, groWth conditions and enZymatic analysis. Yeasts
Were groWn in minimal glycerol media (MGY: 1.34% yeast

nitrogen base Without amino acids, 1% glycerol, 4><10_5%
biotin) and transformed cells Were selected on Minimal

method, the sequence is contained in a vector that carries a
selectable marker and transfected into the host cell or the

Dextrose (MD) plates (1.34% yeast nitrogen base Without

selectable marker is co-transfected into the host cell along

agar). If required 0.0004% histidine Was added to the media.

amino acids (YNB), 2% glucose, 4><10_5% biotin and 1.5%

With the sequence of interest. Lines of host cells are then

selected in Which the number of copies of the sequence have
been ampli?ed. Anumber of suitable selectable markers Will
be readily apparent to those skilled in the art. For example,

The cells Were groWn on Minimal Methanol (MM, 1.34%
65

YNB, 4><10_5% biotin, 0.5% methanol) and Minimal
Methanol-Ethanol (MME, 1.34% YNB, 4><10_5% biotin,
0.5% methanol and 0.5% ethanol) until the optical density

US 6,699,691 B2
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(600 nm) reached to 1.5—2.0 at 30° C. [3-Gal activity Was

ABC (SEQ ID NO: 16, SEQ ID NO: 17, and SEQ ID NO:

assayed using ONPG (o-Nitrophyenyl B-D

18, respectively) ABCD (SEQ ID NO: 16, SEQ ID NO: 17,
SEQ ID NO: 18, and SEQ ID NO: 19, respectively),

glactopyranoside) as reported by Miller, J. H. Assay of
[3-galactosidase. in Miller, J. H. (ed), Experiments in
Molecular Genetic, Cold Spring Harbor Laboratory, pp.

respectively. These fragments Were inserted into the expres

sion plasmids carrying the sequential deletion derivatives of

the AOX1 promoter, pAL285, pAL424, pAL551, pAL669,

352—355 (1972) incorporating the modi?cation proposed by
Guarente and Ptashne, Fusion of Escherichia coli lacZ to the
cytochrome c gene of Saccharomyces cerevisiae. Proc. Natl.
Acad. Sci. USA 78, 2199—203 (1981). The cells Were per
meabiliZed With chloroform and sodium dodecyl sulfate
(SDS) and the results Were reported in Miller Units.

and the plasmids Were named pALD1, pALD2, pALD3 and

pALD4, respectively. Consequently each PALD plasmid
10

General DNA Techniques.

respectively.
In order to purify the regions of the fragments (B (SEQ ID
NO: 17), C (SEQ ID NO: 18), D (SEQ ID NO: 19) and E

Restriction enZymes and primers Were from NeW England

Biolabs Inc. (Beverly, Mass.), Site Directed Mutagenesis

(SEQ ID NO: 20)) for band shift assay, a second round of
site directed mutagenesis Was done. The pMMI132,

(SDM) Was performed With the Altered Sites® II in vitro

Mutagenesis System from Promega (Madison, Wis.) accord

lacks B (SEQ ID NO: 17), C (SEQ ID NO: 18), D (SEQ ID
NO: 19) and E (SEQ ID NO: 20) promoter fragments

15

pMMI285, pMMI424, pMMI551 ssDNAs and AOXRI285,

ing to the manufacturer’s recommendations. Primers Were

AOXRi424, AOXRI551 and AOXR1669 primers Were used

purchased from Sigma/Genosys (The Woodlands, Tex.).

for SDM (site directed mutagenesis) reactions to drop B
(SEQ ID NO: 17), C (SEQ ID NO: 18), D (SEQ ID NO: 19)
and E (SEQ ID NO: 20) fragment, respectively. For
example, to purify fragment B (SEQ ID NO: 17), pMMI132

Protocols for the system Were folloWed as described in the
technical manual. All other DNA manipulations Were as

previously described (Sambrook, et al., (1989) Molecular
Cloning: A Laboratory Manual). A 1.5 Kb HIS4 fragment

20

single stranded DNA and primer AOX1285 Were used to
insert a third EcoRI site into the AOX1 promoter. After sited

from pAL2 Was used for Southern analysis to select single
copy transformants.
Plasmid Constructions.
The plasmid pSAOH5 Was ?rst used as the parental

plasmid to characteriZe the regulation of LacZ gene under
the control of the AOX1 promoter of R pastoris. pAL2, an
integrating plasmid, Was constructed because of instability
of the plasmid pSAOH5 in R pastoris. The 3.6 kb Eco
RI-Nru I fragment of pSAOH5 Was inserted in the Eco
RI-Sma I region of the pIB1, promoter less Pichia expres
sion vector, and pAL2 parental plasmid Was obtained. The
Eco RI/Nru I fragment of pSAOH5 contained the 5‘ untrans
lated region and ?rst 15 amino acids of AOX1 fused to the
lacZ gene at codon nine. The mutagenesis plasmid,
pMMI101, Was constructed by inserting a 1120 base pair

25

directed mutagenesis, each of fragments A (SEQ ID NO:
16), B (SEQ ID NO: 17), C (SEQ ID NO: 18), D (SEQ ID
NO: 19), E (SEQ ID NO: 20) and F (SEQ ID NO: 21) Was
gel puri?ed With a Gene Clean II Kit (Bio101, Inc. Vista,

Calif.).
Prior to transformation, the deletion and chimen c plas
30

mids Were digested With Stu I, Which cuts the vectors once
Within the HIS4 sequences to direct the integration event in
the his4 locus of the host GS115 strain. Transformants Were
selected on MD media Which lacks histidine. A single copy

of the plasmids of transformed strains of transformed strains
Was determined by Southern blot assay. At least three
35

independent single-copy transformants Were chosen,
induced in MM media, and [3-Gal activity Was monitored in
the strains. One representative strain Was used for further

Eco RI-Bam HI fragment of pSAOH5 into pALTER-1 (FIG.

studies. At least three independent induction experiments in

1).

MM and MME media Were done to estimate the [3-gal

The plasmids containing 5‘ deletion derivatives of the
AOX1 promoter Were constructed using the Altered Sites®
II in vitro Mutagenesis System to insert Eco RI sites at

40

activity.
DNA Probes for Gel Shift Assays.
Second round SDM (site directed mutagenesis) Was done

various positions along the promoter element. The primers
used to obtain 5‘ deletion derivatives of the AOX1 promoter

to purify plasmids pMMI132, pMMI285, pMMI424,

are as folloWs;

pMMI551 to release fragments B (SEQ ID NO: 17), C (SEQ
ID NO: 18), D (SEQ ID NO: 19) and E (SEQ ID NO: 20),
respectively. The Eco RI fragment of pMMI132 and the Eco

45

RI/Sma I fragment of pMMI669 Were used as fragments A

AOXRI132

5'—ACGCAGGAATTCCTCCACTC—3'

(SEQ ID NO: 22)

(SEQ ID NO: 16) and F (SEQ ID NO: 21), respectively.

AoxRI285

5'—GGCGAGGAATTCATGTTTGT—3'

(SEQ ID NO: 23)

50

Each fragment Was puri?ed from agarose gel and end
labeled With DNA polymerase using infrared labeled DATP

(Li-Cor Inc, Lincoln, Nebr.)
AoxRI424

5'—GTCTTGGAATTCCTAATATGAC—3'

Preparation of Yeast Cell Extracts.
(SEQ ID NO: 24)

Yeasts Were groWn in 25 ml of MM or MME media at 30°

C. to 1.5 OD (600 nm). The cells Were centrifuged at

AOXRI551

5'—GGTATTGAATTCACGAATGCTC—3'

(SEQ ID NO: 25)

55

bitol and suspended in 500 ml of Buffer C [20 mM HEPES
pH 8.0, 0.2 mM EDTA, 0.5 mM dithiotretiol (DTT), 0.5 mM

AOXRI699

5'—CTTCCAAGAATTCTGGTGGG—3'

(SEQ ID NO: 26)

The mutant plasmids (pMMI132-pMMI669) Were
digested With Eco RI/Sma I, and the fragments Were
exchanged With the native AOX1 promoter in pAL2.

PMSF (phenylmethylsulfonyl ?uoride), 0.42 M NaCl, 1.5
60

19,000><g for 15 minutes at 4° C., the supernatant Was used
for gel retardation assays. Total protein from cell extracts

plasmids, pMMI132, pMMI285, pMMI424 and pMMI551
upstream AOX1 promoter fragments, A (SEQ ID NO: 16),
AB (SEQ ID NO: 16 and SEQ ID NO: 17, respectively),

mM MgCl2 and 25% glycerol]. The cells Were broken With
glass beads (0.45—0.5 mmin diameter) in a bead beater

(Biospec Products) (7><30 sec). After centrifugation at

The construction of PALD series Which remove internal
AOX1 promoter sequences Was as folloWs: PMMI series of

Which carry the mutant Eco RI sites and deletes the 5‘

2,000><g at room temperature, Washed tWice With 1M sor

Was estimated by the BCA assay (Pierce) using BSA as a
65

standard protein.
Gel retardation assay. The binding reaction mixtures
contained 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM

US 6,699,691 B2
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DTT, 2 mg of poly (dI-dC)'poly (dI-dC) (deoxyinosine
deoxycytosine), 0.05% Nonidet-40, 10% glycerol and end

unlabeled competitor and unlabeled nonspeci?c DNA
(Lanes 3 and 5). TWo mg poly dI.dC poly dI.dC and 500-bp

labeled DNA in a volume of 20 ml. The binding reaction
mixtures included 6 mg of protein extract. After 20 min of

Listeria moncytogenes gene product Were used as nonspe

incubation at room temperature, mixtures Were loaded on to

ci?c DNAs. The addition of competitor (unlabeled A

a 6% non-denaturing pre-casted polyacrylamide gel (Novex,

fragment) resulted in loss of the signal (lane 3).

Carlsbad, Calif.). Electrophoresis Was carried out at 10 v/cm
of gel for 90 min in TBE (45 mM Tris/borate, 1 mM EDTA).

Furthermore, addition of the unlabeled fragment C (SEQ ID
NO: 18)(lane 4) did not compete With fragment A (SEQ ID
NO: 16) implying that DNA binding for the fragment C
(SEQ ID NO: 18) is speci?c and the protein binding to
fragmentA(SEQ ID NO: 16) does not form a complex With

The gels Were dried and scanned With a prototype Y-axis

scanner using Base ImagIR v. 4.0 softWare (Li-Cor, Lincoln,

Nebr.).

10

Results
Regulation of Deletion Derivatives of AOX1 Promoter.

The plasmids carrying sequential deletions (pAL series)
and dropout mutations (pDAL series) Were integrated into
the his4 locus of chromosome of R pastoris GS115 strain
and single-copy transformants Were screened by Southern

15

blot analysis (results not shoWn). At least three single-copy
transformants Were screened by [3-gal expression in MM
medium, and one representative strain Was used for further
induction experiments. Each transformant Was cultured in

Extract from ethanol/methanol groWn cells forms a com

Were groWn to an optical density of 1.5—2.0 (600 nm) prior

plex With fragment C (SEQ ID NO: 18), but the intensity of
25

groWn cells containing pAL2.
30

35

The sequential deletions do not alWays re?ect the relative
promoter activity since the cumulative effect of cis-acting
sequences is neglected. Therefore, a series of AOX1 pro
moter derivatives Were constructed With internal deletions

(pALDs) to determine the exclusive effect of each fragment.
Only loss of sequences B (SEQ ID NO: 17) and E (SEQ ID
NO: 20) had a signi?cant effect on lacZ expression, sug
gesting that positive elements are located Within these
deletion intervals. The most signi?cant effect on [3-gal
activity Was observed by deletion of the fragment E (SEQ ID
NO: 20)(—390/—239) Where the AOX1 promoter lost 84% of

the signal Was Weaker than that observed With methanol
groWn cells using the same amount of total cell extract (6 mg

total protein).

Each of the deletion derivatives of the AOX1 promoter

severe effect on the expression.

did not compete for the protein (FIG. 4, lanes 4,8 and lanes

5, 9, respectively).

MGY (minimal glycerol media) media overnight. The cul

decreased [3-Gal activity in MM media compared to the
native promoter (FIG. 2). Loss of fragment D (SEQ ID NO:
19)(—518/—390) (pAL551) resulted in about a tWo-fold
increase of [3-gal activity, relative to pAL424, While loss of
fragment E (SEQ ID NO: 20) (—390/—239) had the most

and total protein extracted from yeast cells under induced
and un-induced conditions revealed the formation of speci?c
DNA-protein complexes. In this case the fragment A (SEQ

ID NO: 16) and nonspeci?c DNA (L. monocytogenes DNA)
20

ture Was used to inoculate MM and MME media, With cells

to harvesting. The activity of the AOX1-lacZ fusion Was
measured and reported as percent of activity of methanol

fragment C (SEQ ID NO: 18).
The gel shift assay using fragment C (SEQ ID NO: 18)

The gel shift assays using the fragments B (SEQ ID NO:
17), D (SEQ ID NO: 19), E (SEQ ID NO: 20), and F (SEQ
ID NO: 21) did not reveal any DNA-protein complexes,
although different gel-shift experiment conditions Were
tested (results not shoWn). The gel shift results of the
fragment F (SEQ ID NO: 21) is shoWn in FIG. 5.
Additionally, FIG. 6 depicts consensus sequences of metha

nol regulated promoters of methylotrophic yeast.
40

In light of the detailed description of the invention and the
examples presented above, it can be appreciated that the
several aspects of the invention are achieved.

It is to be understood that the present invention has been
45

described in detail by Way of illustration and example in
order to acquaint others skilled in the art With the invention,

its principles, and its practical application. Particular for
mulations and processes of the present invention are not

activity.

limited to the descriptions of the speci?c embodiments

Although the deletion derivatives of the AOX1 promoter
had a signi?cant effect on the promoter activity of methanol

presented, but rather the descriptions and examples should

groWn cells, the deletion and dropout plasmids did not
impair ethanol induced repression of the AOX1 promoter

equivalents. While some of the examples and descriptions

(FIG. 2).

may function, the inventor does not intend to be bound by
those conclusions and functions, but puts them forth only as

Gel Retardation Assays.

be vieWed in terms of the claims that folloW and their
above include some conclusions about the Way the invention
55

The GS115 (pAL2) strain Was used to obtain total protein

possible explanations.

extracts groWing in repressed (MME) or induced (MM)
conditions. The fragments A, B, C, D, E and F (SEQ ID NO:
16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ
ID NO: 20, and SEQ ID NO: 21, respectively) Were tested

It is to be further understood that the speci?c embodi
ments of the present invention as set forth are not intended
60

in gel-shift assays. The fragment A (SEQ ID NO: 16)
resulted in formation of speci?c DNA-protein complex

as being exhaustive or limiting of the invention, and that
many alternatives, modi?cations, and variations Will be
apparent to those of ordinary skill in the art in light of the

When the cells Were groWn under induced condition

foregoing examples and detailed description. Accordingly,

(methanol) (FIG. 3, lane 2). HoWever, the ethanol groWn

this invention is intended to embrace all such alternatives,

cell-protein extracts did not reveal any DNA-protein com

plexes (FIG. 3, lane 6). Speci?city Was tested by adding

65

modi?cations, and variations that fall Within the spirit and
scope of the folloWing claims.
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SEQUENCE LISTING

<l60> NUMBER OF SEQ ID NOS: 29

SEQ ID NO 1
LENGTH: 1052
TYPE: DNA

ORGANISM: Pichia pastoris
<400> SEQUENCE:

l

aattcccgct ttgatgcctg aaatcccagc gcctacaatg atgacatttg gatttggttg

60

actcatgttg gtattgtgaa atagacgcag atcgggaaca ctgaaaaata acagttatta

120

ttcgagatct

aacatccaaa

gacgaaaggt tgaatgaaac ctttttgcca tccgacatcc

180

acaggtccat

tctcacacat

aagtgccaaa cgcaacagga ggggatacac tagcagcaga

240

ccgttgcaaa cgcaggactc

atcctcttct ctaacaccat

tttgcatgaa aacagccagt

300

tatgggcttg atggagctcg

ctcattccaa ttccttctat

taggctacta acaccatgac

360

tttattagcc tgtctatcct ggcccccctg gcgaggtcat gtttgtttat ttccgaatgc

420

aacaagctcc gcattacacc cgaacatcac tccagatgag ggctttctga gtgtggggtc

480

aaatagtttc atgttcccaa atggcccaaa actgacagtt taaacgctgt cttggaacct

540

aatatgacaa aagcgtgatc tcatccaaga tgaactaagt ttggttcgtt gaaatcctaa

600

cggccagttg gtcaaaaaga

aacttccaaa

agtcgccata ccgtttgtct tgtttggtat

660

tgattgacga atgctcaaaa

ataatctcat

taatgcttag cgcagtctct ctatcgcttc

720

tgaacccggt ggcacctgtg ccgaaacgca aatggggaaa caacccgctt tttggatgat

780

tatgcattgt

840

cctccacatt

gtatgcttcc aagattctgg tgggaatact gctgatagcc

taacgttcat gatcaaaatt taactgttct

aacccctact

tggacaggca

atatataaac

900

taaacctttt tttttatcat

cattattagc

ttactttcat

960

aattgcgact ggttccaatt gacaagcttt tgattttaac gacttttaac gacaacttga

1020

gaagatcaaa

1052

agaaggaagc

tgccctgtct

aaacaactaa

ttattcgaaa

<2l0> SEQ ID NO 2
<2ll> LENGTH: 1757
TYPE: DNA

ORGANISM: Pichia pastoris
<400> SEQUENCE: 2

ggatctcaaa aacctaagta cttcatttga

gcacctaaaa

tttacaccta

60

taggctctag atttgataga ttctatagcc tttggtttgt tatagtgttc

120

accaactgga tgtcctaacg aaatggttct gtggtctagt tggttatggc atatgcttaa

180

tccccagttc gatcctgggc agaatcatta ttttttgacc gaattctttt

240

actctctatc

cacgcaaacg

atataactct

tttcagacca tatgaccggt

ccatcttcta

Cggggggatt atctatgctt tgacctctat

300

cttgattctt ttatgattca

aatcactttt

acgttattta ttacttactg gttatttact

360

tagcgccttt tctgaaaaac

atttactaaa aatcatacat

cggcactcta aacacgacag

420

attgtgatca agaagcagag

acaatcacca

ctaaggttgc acatttgagc cagtaggctc

480

ctaatagagg ttcgatactt attttgataa tacgacatat tgtcttacct ctgaatgtgt

540

acacttcgag taagatacgc

600

ccaattgaag gctacgagat accagactat cactagtaga actttgacat ctgctaaagc

660

agatcaaata

720

caatactctc

tcgttcttcg tctcgtcagc

tccatttatc

cagaatcaat

taaaaatata

taccttcctt

tagcttgtcg aaggcatgaa

US 6,699,691 B2
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23
-continued
aaCaaaaaCa aCtaattatt CgaaaCaatg gCtattCCCg aagaatttga tattatCgtC

1080

tgtggtggtg gatCC

1095

SEQ ID NO 4
LENGTH: 21
TYPE: DNA
ORGANISM: Yeast
FEATURE:

NAME/KEY: miscifeature
LOCATION:

(41) . . (4 )

OTHER INFORMATION: n=unknown
FEATURE:

NAME/KEY: miscifeature
LOCATION:

(5) . . (5 )

OTHER INFORMATION: n=unknown
FEATURE:

NAME/KEY: miscifeature
LOCATION:

(6) . . (6)

OTHER INFORMATION: n=unknown
FEATURE:

NAME/KEY: miscifeature
LOCATION:

(16) . . (16)

OTHER INFORMATION: n=unknown
FEATURE:

NAME/KEY: miscifeature
LOCATION: (17 ) . . ( 17)
OTHER INFORMATION: n=unknown
FEATURE:

NAME/KEY: miscifeature
LOCATION: (15 ) . . ( 15)
OTHER INFORMATION: n=unknown

SEQUENCE: 4

ttgnnngctt CCaannntgg t

21

SEQ ID NO 5
LENGTH: 10
TYPE: DNA
ORGANISM: Yeast
FEATURE:

NAME/KEY: miscifeature
LOCATION:

(3) . . (3)

OTHER INFORMATION: n=unknown

SEQUENCE: 5

CCnCtttttg

10

SEQ ID NO 6
LENGTH: 16
TYPE: DNA
ORGANISM: Yeast

SEQUENCE: 6

gCtCattCCa attCCt

16

SEQ ID NO 7
LENGTH: 16
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: 7

CtgtCttgga aCCtaa

SEQ ID NO 8
LENGTH: 16
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: 8

16
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26
-continued

gaaacttcca aaagtc
SEQ ID NO 9
LENGTH: 16
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: 9

tatgcttcca agattc
SEQ ID NO 10
LENGTH: 16
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: l0

actggttcca attgac
SEQ ID NO 11
LENGTH: 15
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: ll

cctgtctatc ctggc
SEQ ID NO 12
LENGTH: 15
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: l2

tctctctatc gcttc

SEQ ID NO 13
LENGTH: 15
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: l3

ctgctgatag cctaa

SEQ ID NO 14
LENGTH: 15
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: l4

gagttcgagg tcgtg
SEQ ID NO 15
LENGTH: 15
TYPE: DNA

ORGANISM: methylotrophic yeast
SEQUENCE: l5

gagtgtgggg tcaaa

SEQ ID NO 16
LENGTH: 256
TYPE: DNA

ORGANISM: Pichia pastoris

